ACS Fall 2026

Date: August 23-27, 2026
Venue: McCormick Place Convention Center, Chicago, IL - Medicilon Booth #400
Facebook
LinkedIn
SAVE THE DATES

Medicilon at ACS Fall 2026 – Booth #400 in Chicago

We are pleased to announce that Medicilon will attend the ACS Fall 2026 – one of the world’s largest gatherings of chemistry professionals, hosted by the American Chemical Society. This premier scientific meeting brings together more than 10,000 chemists, researchers, educators, and industry leaders from across the globe to share knowledge, showcase groundbreaking discoveries, and collaborate on solutions to global challenges.

Venue:McCormick Place Convention Center, Chicago, IL – Medicilon Booth #400

Date: August 23-27, 2026

2026 marks ACS’ 150th Anniversary – a historic milestone celebrating 150 years of advancing chemistry, built on discovery, innovation, and community. Under the theme “Chemists Making History”, we look forward to showcasing our full-spectrum chemistry R&D platforms – and giving you a glimpse of how our integrated preclinical services can support your program from hit to IND.

Meet our team on site

  • Dr. Mingfeng Bai – SVP of Business Development
  • Dr. Steven Zhang – VP of Drug Discovery
  • Dr. Gillian Sun – Manager of Business Development

What We Highlight at RACI 2026 – Chemistry & Technology Platforms

With 650+ IND approvals supported worldwide (FDA, NMPA, EMA, TGA, MFDS, PMDA), Medicilon provides a full spectrum of chemistry R&D services under one roof.

Medicinal Chemistry

  • Focused library construction, activity screening & hit identification
  • Lead generation, SAR development, lead optimization, PCC selection

Process Chemistry

  • Reference scale-up, hundred gram to kilo gram synthesis
  • Lead/PCC compound scale-up for animal studies
  • Early stage process study of advanced compounds

Custom Synthesis

  • Special reagents / intermediates synthesis
  • Reference / standard synthesis
  • Special impurities / metabolites synthesis
  • Stable isotope internal standards synthesis

Technology Platforms

  • Small molecule, TPD, XDC, RNAi, Peptide, AIDD…

Beyond Chemistry – Let’s Talk About Your Full Program

While our booth focuses on chemistry capabilities, Medicilon also offers biology, PD/PK, CMC, and regulatory support as part of our integrated preclinical CRO services.

With over 22 years of industry experience and 2,000+ client R&D programs supported globally, we’re ready to help accelerate your drug discovery journey. Come talk to the Medicilon team – we’d be happy to discuss how we can support your entire journey from hit to IND, beyond chemistry.

See you in Chicago!

ACS Fall 2026

Meet the Medicilon team by filling out the form below:

Name(Required)
Address

Search Medicilon

Preclinical CRO

ACS Fall 2026

Preclinical CRO

【BRIDGE】Medicilon XDC Innovation Forum · Seoul 2026

Preclinical CRO

World’s First Phase III Positive B7-H3 ADC: Medicilon Congratulates MediLink Therapeutics on NDA Acceptance of Icontamrotamab

Contact Medicilon

Name(Required)
Address(Required)